Related Experiment Video
Updated: Feb 6, 2026
09:31
Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients
Published on: October 16, 2016
9.9K
Expert Recommendations on the Interleukin 6 Blockade in Patients with Rheumatoid Arthritis
Jesús Tornero Molina1, Alejandro Balsa Criado2, Francisco Blanco García3
1Servicio de Reumatología, Hospital Universitario de Guadalajara; Departamento de Medicina y Especialidades Médicas, Universidad de Alcalá, España.
Reumatologia Clinica
|August 13, 2018
Summary
This study provides 8 expert-backed recommendations for using interleukin 6 (IL-6) blockade in rheumatoid arthritis (RA) treatment, guiding clinical decisions for better patient outcomes.
Area of Science:
- Rheumatology
- Immunology
- Pharmacology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease.
- Interleukin 6 (IL-6) blockade represents a significant therapeutic advancement in RA management.
- Optimal utilization of IL-6 inhibitors requires clear clinical guidance.
Purpose of the Study:
- To develop evidence-based recommendations for IL-6 blockade in RA.
- To address key clinical questions regarding IL-6 inhibitor therapy.
- To support decision-making for clinicians treating RA patients.
Main Methods:
- A systematic literature review was performed.
- A panel of 10 experts in IL-6 blockade for RA was convened.
- Recommendations were formulated using a Delphi technique with 2 rounds of voting.
Main Results:
- Eight preliminary recommendations were finalized after expert consensus.
- Recommendations cover monotherapy, combination therapy, refractory disease, intolerance, response evaluation, optimization, and risk management.
- High levels of agreement were achieved among experts (≥80% consensus).
Conclusions:
- The developed recommendations provide practical guidance for IL-6 blockade in RA.
- This consensus-based approach aims to standardize and improve IL-6 inhibitor use.
- The findings will aid clinicians in optimizing treatment strategies for RA patients.
Related Concept Videos
01:29Neuromuscular Junction And Blockade
5.1K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
5.1K
01:13Patient-centered Care
3.1K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.1K
01:15Drug Dosing: Geriatric Patients
278
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
278
01:21Drug Dosing: Obese Patients
268
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
268
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
239
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
239
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
266
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266